<DOC>
	<DOCNO>NCT01995370</DOCNO>
	<brief_summary>To examine efficacy safety dual antiplatelet therapy ( DAPT ) include cilostazol ( Pletaal OD Tablet ® ) comparison antiplatelet monotherapy ( exclude cilostazol ) secondary prevention ischemic stroke high-risk patient stroke</brief_summary>
	<brief_title>Cilostazol Stroke Prevention Study Antiplatelet Combination</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cerebral Infarction</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Patients diagnosis noncardioembolic IS develop 8 180 day start protocol treatment Patients responsible lesion identify MRI Patients age 20 85 year old providing informed consent Patients take clopidogrel aspirin alone antiplatelet therapy provide informed consent Patients meet least one follow criterion a−c : 1. least 50 % stenosis major intracranial artery ( level A2 , M2 , P2 ) 2. least 50 % stenosis extracranial artery ( common carotid artery，internal carotid artery，vertebral artery，brachiocephalic artery，or subclavian artery ) 3 . Two follow risk factor Aged 65 year Diabetes mellitus Hypertension Peripheral arterial disease Chronic kidney disease History IS ( exclude index IS study ) History ischemic heart disease Smoking ( current smoker ) Patients consider able visit study site ambulatory care throughout observation period Patients provide write informed consent Patients emboligenic heart disease Patients take anticoagulant agent Patients undergo MRI examination reason claustrophobia implant pacemaker Patients schedule undergo surgery , percutaneous angioplasty , stent placement , bypass grafting , study period Patients drugeluting coronary stent implant within one year Patients history symptomatic nontraumatic intracranial hemorrhage , hemorrhagic disease ( eg , active peptic ulcer ) , bleed predisposition , blood clot disorder Patients history hypersensitivity cilostazol Patients congestive heart failure uncontrolled angina pectoris Patients thrombocytopenia ( platelet count ≦ 100,000/mm3 ) Patients severe liver renal dysfunction Women pregnant , breastfeeding , childbearing potential Patients malignant tumor require treatment Patients take aspirin , meet follow criterion : History hypersensitivity aspirin salicylic acid analogue Current peptic ulcer Aspirininduced asthma history Patients take clopidogrel , meet following criterion : ・History hypersensitivity clopidogrel Patients participate clinical study Patients consider investigator/subinvestigator unsuitable participating study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Noncardioembolic cerebral infarction</keyword>
	<keyword>Dual antiplatelet therapy ( DAPT )</keyword>
	<keyword>Cilostazol</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Clopidogrel</keyword>
</DOC>